
Eric Burton Grimes
Examiner (ID: 1812)
| Most Active Art Unit | 1814 |
| Art Unit(s) | 1652, 1814 |
| Total Applications | 291 |
| Issued Applications | 166 |
| Pending Applications | 38 |
| Abandoned Applications | 87 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19768286
[patent_doc_number] => 20250049712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => HIGH-EFFICIENCY AND LOW-TOXICITY DNA AND RNA LIPID DELIVERY CARRIER
[patent_app_type] => utility
[patent_app_number] => 18/721013
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18721013
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/721013 | HIGH-EFFICIENCY AND LOW-TOXICITY DNA AND RNA LIPID DELIVERY CARRIER | Dec 14, 2022 | Pending |
Array
(
[id] => 18311793
[patent_doc_number] => 20230115693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => FORMULATIONS OF BENDAMUSTINE
[patent_app_type] => utility
[patent_app_number] => 18/081251
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081251
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/081251 | Formulations of Bendamustine | Dec 13, 2022 | Issued |
Array
(
[id] => 18836726
[patent_doc_number] => 11844783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Formulations of bendamustine
[patent_app_type] => utility
[patent_app_number] => 18/081238
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5323
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/081238 | Formulations of bendamustine | Dec 13, 2022 | Issued |
Array
(
[id] => 18634855
[patent_doc_number] => 11759426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-19
[patent_title] => Centanafadine pharmaceutical formulations, and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 18/072473
[patent_app_country] => US
[patent_app_date] => 2022-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 21
[patent_no_of_words] => 57468
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18072473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/072473 | Centanafadine pharmaceutical formulations, and methods of making and using same | Nov 29, 2022 | Issued |
Array
(
[id] => 19622826
[patent_doc_number] => 12161617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Methocarbamol compositions and related methods
[patent_app_type] => utility
[patent_app_number] => 18/070134
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14413
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070134 | Methocarbamol compositions and related methods | Nov 27, 2022 | Issued |
Array
(
[id] => 19691115
[patent_doc_number] => 20250009660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => LIPID COMPOUND, LIPOSOME, EXOSOME, LIPID NANOPARTICLE, AND DRUG DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/711129
[patent_app_country] => US
[patent_app_date] => 2022-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18711129
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/711129 | LIPID COMPOUND, LIPOSOME, EXOSOME, LIPID NANOPARTICLE, AND DRUG DELIVERY SYSTEM | Nov 24, 2022 | Pending |
Array
(
[id] => 20005789
[patent_doc_number] => 20250144011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => MICRONEEDLE FORMULATION, MICRONEEDLE PATCH, AND PREPARATION METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/832426
[patent_app_country] => US
[patent_app_date] => 2022-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18832426
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/832426 | MICRONEEDLE FORMULATION, MICRONEEDLE PATCH, AND PREPARATION METHODS THEREOF | Nov 22, 2022 | Pending |
Array
(
[id] => 18434498
[patent_doc_number] => 20230181792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => METHODS OF PRODUCING AN OSTEOINDUCTIVE CALCIUM PHOSPHATE MATERIAL FOR BONE GRAFTING
[patent_app_type] => utility
[patent_app_number] => 17/991157
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17991157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/991157 | METHODS OF PRODUCING AN OSTEOINDUCTIVE CALCIUM PHOSPHATE MATERIAL FOR BONE GRAFTING | Nov 20, 2022 | Abandoned |
Array
(
[id] => 18256795
[patent_doc_number] => 20230083835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => DEVICES AND METHODS FOR DELIVERY OF SUBSTANCES TO ANIMALS
[patent_app_type] => utility
[patent_app_number] => 17/987983
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17987983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/987983 | Devices and methods for delivery of substances to animals | Nov 15, 2022 | Issued |
Array
(
[id] => 19535601
[patent_doc_number] => 12128134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Devices and methods for delivery of substances to animals
[patent_app_type] => utility
[patent_app_number] => 17/987989
[patent_app_country] => US
[patent_app_date] => 2022-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 34
[patent_no_of_words] => 20630
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17987989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/987989 | Devices and methods for delivery of substances to animals | Nov 15, 2022 | Issued |
Array
(
[id] => 20362731
[patent_doc_number] => 20250352543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-20
[patent_title] => NANOCRYSTALLINE PREPARATION OF ROCK2 INHIBITOR AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/710713
[patent_app_country] => US
[patent_app_date] => 2022-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18710713
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/710713 | NANOCRYSTALLINE PREPARATION OF ROCK2 INHIBITOR AND PREPARATION METHOD THEREFOR | Nov 14, 2022 | Pending |
Array
(
[id] => 20039075
[patent_doc_number] => 20250177297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => OIL-IN-WATER EMULSION COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/842107
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18842107
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/842107 | OIL-IN-WATER EMULSION COMPOSITION | Nov 9, 2022 | Pending |
Array
(
[id] => 18351417
[patent_doc_number] => 20230139528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => POLYMER LUNG SURFACTANTS
[patent_app_type] => utility
[patent_app_number] => 18/054082
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054082
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054082 | Polymer lung surfactants | Nov 8, 2022 | Issued |
Array
(
[id] => 18213698
[patent_doc_number] => 20230059964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => Method for Coating Pharmaceutical Substrates
[patent_app_type] => utility
[patent_app_number] => 17/978700
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17978700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/978700 | Method for coating pharmaceutical substrates | Oct 31, 2022 | Issued |
Array
(
[id] => 18366635
[patent_doc_number] => 20230148226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => COMPOSITIONS OF STABLE FORMULATIONS OF VARENICLINE SALT OR BASE FORM WITH CONTROL ON NITROSO IMPURITIES
[patent_app_type] => utility
[patent_app_number] => 17/976040
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17976040
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/976040 | COMPOSITIONS OF STABLE FORMULATIONS OF VARENICLINE SALT OR BASE FORM WITH CONTROL ON NITROSO IMPURITIES | Oct 27, 2022 | Pending |
Array
(
[id] => 18179990
[patent_doc_number] => 20230040719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => Pharmaceutical Formulation with Improved Solubility and Bioavailability
[patent_app_type] => utility
[patent_app_number] => 17/972172
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17972172
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/972172 | Pharmaceutical formulation with improved solubility and bioavailability | Oct 23, 2022 | Issued |
Array
(
[id] => 19921590
[patent_doc_number] => 12295848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Implants including modified demineralized cortical bone fibers and methods of making same
[patent_app_type] => utility
[patent_app_number] => 17/966092
[patent_app_country] => US
[patent_app_date] => 2022-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 10153
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966092
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966092 | Implants including modified demineralized cortical bone fibers and methods of making same | Oct 13, 2022 | Issued |
Array
(
[id] => 20593447
[patent_doc_number] => 12577148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Ceramic composition comprising antimicrobial glass composition
[patent_app_type] => utility
[patent_app_number] => 17/965209
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965209
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/965209 | Ceramic composition comprising antimicrobial glass composition | Oct 12, 2022 | Issued |
Array
(
[id] => 19496514
[patent_doc_number] => 20240335532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => NANOPARTICULATE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/700024
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700024
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700024 | NANOPARTICULATE FORMULATION | Oct 10, 2022 | Pending |
Array
(
[id] => 19496514
[patent_doc_number] => 20240335532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => NANOPARTICULATE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/700024
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700024
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700024 | NANOPARTICULATE FORMULATION | Oct 10, 2022 | Pending |